Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Jun;141(6):1493-1502.
doi: 10.1016/j.jid.2020.11.025. Epub 2020 Dec 30.

Causal Relationship and Shared Genetic Loci between Psoriasis and Type 2 Diabetes through Trans-Disease Meta-Analysis

Affiliations
Meta-Analysis

Causal Relationship and Shared Genetic Loci between Psoriasis and Type 2 Diabetes through Trans-Disease Meta-Analysis

Matthew T Patrick et al. J Invest Dermatol. 2021 Jun.

Abstract

Psoriasis and type 2 diabetes (T2D) are complex conditions with significant impacts on health. Patients with psoriasis have a higher risk of T2D (∼1.5 OR) and vice versa, controlling for body mass index; yet, there has been a limited study comparing their genetic architecture. We hypothesized that there are shared genetic components between psoriasis and T2D. Trans-disease meta-analysis was applied to 8,016,731 well-imputed genetic markers from large-scale meta-analyses of psoriasis (11,024 cases and 16,336 controls) and T2D (74,124 cases and 824,006 controls), adjusted for body mass index. We confirmed our findings in a hospital-based study (42,112 patients) and tested for causal relationships with multivariable Mendelian randomization. Mendelian randomization identified a causal relationship between psoriasis and T2D (P = 1.6 × 10‒4, OR = 1.01) and highlighted the impact of body mass index. Trans-disease meta-analysis further revealed four genome-wide significant loci (P < 5 × 10‒8) with evidence of colocalization and shared directions of effect between psoriasis and T2D not present in body mass index. The proteins coded by genes in these loci (ACTR2, ERLIN1, TRMT112, and BECN1) are connected through NF-κB signaling. Our results provide insight into the immunological components that connect immune-mediated skin conditions and metabolic diseases, independent of confounding factors.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

JEG received research grants from AbbVie, AnaptysBio, Pfizer, Novartis, Celgene, and Eli Lilly, and serves as advisory board in Novartis, AbbVie, Eli Lilly, MiRagen, and Almirall. NNM is a full-time US government employee and has served as a consultant for Amgen, Eli Lilly, and Leo Pharma receiving grants/other payments; as a principal investigator and/or investigator for AbbVie, Celgene, Janssen Pharmaceuticals, Inc, and Novartis receiving grants and/or research funding; and as a principal investigator for the National Institute of Health receiving grants and/or research funding.

Figures

Figure 1:
Figure 1:. Trans-disease Meta-analysis.
a) Vertical Manhattan plots of the meta-analysis association results for psoriasis and T2D, showing genome-wide significant (p≤5x10−8) markers in red and shared loci identified by our trans-disease meta-analysis in blue. b) Regional association plots for the chromosome 10 locus in psoriasis and T2D (with the lead marker in purple). The locus is suggestive significant for each disease and genome-wide significant in the trans-disease meta-analysis.
Figure 2:
Figure 2:. Cell Type Enrichment for Trans-Disease Meta-Analysis Markers Outside the MHC.
a) Calculated using DNAse hotspots in GARFIELD. b) Using H3K27ac marks from Farh et al.(Farh et al., 2015) The enrichment results illustrate immune-cell involvement.

Similar articles

Cited by

References

    1. Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet 2013;7:Unit7.20. - PMC - PubMed
    1. American Diabetes Association. Economic Costs of Diabetes in the U.S. in 2017. Diabetes Care 2018;41(5):917–28. - PMC - PubMed
    1. Badr D, Kurban M, Abbas O. Metformin in dermatology: an overview. Journal of the European Academy of Dermatology and Venereology : JEADV 2013;27(11):1329–35. - PubMed
    1. Balasubramanyam M, Aravind S, Gokulakrishnan K, Prabu P, Sathishkumar C, Ranjani H, et al. Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes. Molecular and cellular biochemistry 2011;351(1–2):197–205. - PubMed
    1. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 2015;44(2):512–25. - PMC - PubMed

Publication types

MeSH terms